Chemoinformaics analysis of 2-(1H-INDOL-3-YL)ACETIC ACID
| Molecular Weight | 175.187 | nRot | 2 |
| Heavy Atom Molecular Weight | 166.115 | nRig | 11 |
| Exact Molecular Weight | 175.063 | nRing | 2 |
| Solubility: LogS | -3.679 | nHRing | 1 |
| Solubility: LogP | 2.801 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 10 |
| nHA | 1 | APOL | 25.4051 |
| nHD | 2 | BPOL | 10.4669 |
| QED | 0.584 |
| Synth | 2.564 |
| Natural Product Likeliness | 0.053 |
| NR-PPAR-gamma | 0.205 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.008 |
| CACO-2 | -4.838 |
| MDCK | 0.0000148 |
| BBB | 0.915 |
| PPB | 0.91208 |
| VDSS | 1.237 |
| FU | 0.0459402 |
| CYP1A2-inh | 0.989 |
| CYP1A2-sub | 0.716 |
| CYP2c19-inh | 0.59 |
| CYP2c19-sub | 0.389 |
| CYP2c9-inh | 0.174 |
| CYP2c9-sub | 0.867 |
| CYP2d6-inh | 0.181 |
| CYP2d6-sub | 0.737 |
| CYP3a4-inh | 0.216 |
| CYP3a4-sub | 0.236 |
| CL | 5.811 |
| T12 | 0.542 |
| hERG | 0.006 |
| Ames | 0.605 |
| ROA | 0.081 |
| SkinSen | 0.935 |
| Carcinogencity | 0.621 |
| EI | 0.995 |
| Respiratory | 0.97 |
| NR-Aromatase | 0.32 |
| Antiviral | No |
| Prediction | 0.75576 |